XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Condensed Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net sales $ 304,578 $ 275,088 $ 917,699 $ 794,605
Cost of sales 136,519 123,473 423,629 355,222
Gross profit 168,059 151,615 494,070 439,383
Selling and administrative expense 125,295 114,600 385,080 333,302
Research and development expense 12,464 12,767 38,574 34,932
  Operating expenses 137,759 127,367 423,654 368,234
Income from operations 30,300 24,248 70,416 71,149
Interest expense 10,019 8,536 30,271 19,462
Other expense (See Note 11) 0 0 0 112,011
Income (loss) before income taxes 20,281 15,712 40,145 (60,324)
Provision (benefit) for income taxes 4,444 (30,438) 8,757 46,842
Net income (loss) 15,837 46,150 31,388 (107,166)
Comprehensive income (loss) $ 14,825 $ 43,125 $ 35,287 $ (113,096)
Per share data:        
Basic (in dollars per share) $ 0.52 $ 1.51 $ 1.02 $ (3.59)
Diluted (in dollars per share) $ 0.50 $ 1.48 $ 0.99 $ (3.59)
Weighted average common shares:        
Basic (in shares) 30,741 30,473 30,638 29,892
Diluted (in shares) 31,689 31,103 31,563 29,892